Ignite Creation Date:
2025-12-24 @ 5:07 PM
Ignite Modification Date:
2026-03-02 @ 8:09 PM
Study NCT ID:
NCT07285850
Status:
RECRUITING
Last Update Posted:
2025-12-16
First Post:
2025-08-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Efficacy of Sequential Treatment With Bevacizumab Combined With Atezolizumab in Advanced Liver Cancer With MASLD
Sponsor:
Eastern Hepatobiliary Surgery Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
EHBHKY2024-K023-P011
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None